Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-15 147e388bm72暂无昵称

是不是水刊啊？会剔除SCI吗

122 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-07 146e0980m70暂无昵称

投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。

第三个审稿人reject，但是没有任何意见和review report（迷惑）
另外两个active，各给了三条小意见

编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？

55 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-20 酒久

偏重的研究方向：肿瘤
经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交

67 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-08-16 chensb

投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗

120 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2020-12-09 ms7000001547777208

投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！

106 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-11 51lll

偏重的研究方向：肿瘤
经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？

74 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-19 Fyjcfjbvgj

请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-21 Fyjcfjbvgj

请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了

56 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2021-09-20 GXwangye

偏重的研究方向：肿瘤;免疫微环境
经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1051619, encodeId=486510516198e, content=是不是水刊啊？会剔除SCI吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89655252241, createdName=147e388bm72暂无昵称, createdTime=Wed Sep 15 20:28:58 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015417, encodeId=cca9101541e25, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：请问一下，我现在是interactive阶段，一共三个审稿人。 第三个审稿人reject，但是没有任何意见和review report（迷惑） 另外两个active，各给了三条小意见 编辑让10天内修回，这种有一个无理由拒稿的情况下还有机会吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb605173656, createdName=146e0980m70暂无昵称, createdTime=Tue Sep 07 17:42:51 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053372, encodeId=0a5a10533e22f, content=偏重的研究方向：肿瘤 经验分享：感谢之前各位的帮助，我也来分享一波 20 Sep 2021 编辑一直没通过，换了个编辑accept 07 Sep 2021 另一个审稿人同意发表 04 Sep 2021 大修返修 01 Sep 2021 一修返回，另一个审稿人有意见大修 20 Aug 2021 一个审稿人通过 19 Jul 2021 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/05/78378186fe3e4d812cb33c5822ef564f.jpg, createdBy=f1402426089, createdName=酒久, createdTime=Mon Sep 20 22:54:44 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008443, encodeId=ef64100844358, content=投稿2周了仍然是 Editorial Assignment（No Associate Editor assigned），请问这种状态正常吗？不是说都很快的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3875574818, createdName=chensb, createdTime=Mon Aug 16 20:48:49 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906279, encodeId=7fda9062e9e4, content=投了一个月了，一直在editorial assigment，有一个handling editor名字。请问这种情况是能不能送外审？需要催一下吗？谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0fb95438334, createdName=ms7000001547777208, createdTime=Wed Dec 09 09:01:07 CST 2020, time=2020-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016440, encodeId=01c710164407b, content=偏重的研究方向：肿瘤 经验分享：请问一下，投稿时的文献类型可以让编辑重新更改吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ba15493073, createdName=51lll, createdTime=Sat Sep 11 01:19:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052990, encodeId=af39105299033, content=请问review is ongoing 从下面换到上面，期间一直存在，目前回来了审稿人2。3的意见，是还有审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Sun Sep 19 11:25:41 CST 2021, time=2021-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053432, encodeId=0ad1105343275, content=请好心人解答一下，review is ongoing 位置变到上面，已经5天了，是在找审稿人？找到后又会变到下面？目前已经收到2个审稿人意见了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7fb65143232, createdName=Fyjcfjbvgj, createdTime=Tue Sep 21 09:56:51 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053172, encodeId=acf810531e2a9, content=偏重的研究方向：肿瘤;免疫微环境 经验分享：看了上面很多生信文章才投的，说是生信友好。投稿一周，一直在编辑评估状态，最后被拒，要求实验验证？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f885490162, createdName=GXwangye, createdTime=Mon Sep 20 07:41:17 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886284, encodeId=3e978862845b, content=8.21投稿 8.27independent review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fced5403254, createdName=ms9000000416438768, createdTime=Fri Sep 18 08:26:27 CST 2020, time=2020-09-18, status=1, ipAttribution=)]

2020-09-18 ms9000000416438768

8.21投稿 8.27independent review

129 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务